期刊文献+

癌组织中血管内皮生长因子表达及与微血管生成关系 被引量:3

Relationship between expression of VEGF and MVD in carcinoma
暂未订购
导出
摘要 目的 探讨血管内皮生长因子 (VEGF)在癌组织中的表达及其与癌组织血管生成、病理参数的关系。方法 采用S P免疫组织化学染色法检测 5 6例乳腺癌、5 9例食管癌及其癌旁正常组织各 10例的VEGF表达 ,并记数微血管密度。对每种癌组织各 10例进行VEGFmRNA原位杂交检测。结果 癌组织VEGF表达阳性率高于其正常组织 ,差异具有显著性 (P <0 0 5或P <0 0 1)。VEGF的表达与乳腺癌、食管癌的病理分级密切相关 (P <0 0 5 )。有淋巴结转移的病例 ,其VEGF表达率明显高于无淋巴结转移的病例 (P <0 0 5 )。而且随着VEGF表达的增强 ,癌组织内微血管密度明显增高 (P <0 0 1或P <0 0 5 )。结论 癌组织VEGF表达增强在肿瘤血管生成及生长、转移中起重要作用。 Purpose To clarify the relationship between the expression of vascular endothelial growth factor(VEGF) and the angiogenesis, pathological factors in carcinoma. Methods S-P immunohistochemical method and VEGF mRNA situ hybridization were used to detect the expression of VEGF in 56 cases of breast carcinoma, 59 cases of esophagus carcinoma and 10 cases of adjacent-cancer normal tissues. Results The positivity rate of VEGF in carcinoma were higher than those in normal tissue(P<0.05 or P<0.01). The expression of VEGF were closely related to tumors pathological grade and lymphatic metastasis(P<0.05). A significantly higher microvessel density(MVD) was observed in the carcinoma with positive expression of VEGF compared with those of the negative expression (P<0.05 or P<0.01). Conclusions The up-regulation of VEGF has an important role in angiogenesis, growth and metastases of carcinoma.
出处 《临床与实验病理学杂志》 CAS CSCD 2003年第3期293-295,共3页 Chinese Journal of Clinical and Experimental Pathology
基金 黑龙江省自然科学基金资助项目 (D 0 0 .5 0 )
关键词 癌组织 血管内皮生长因子 基因表达 微血管 生成关系 免疫组织化学 食管肿瘤 乳腺肿瘤 esophageal neoplasms breast neoplasms vascular endothelial growth factor angiogenesis carcinoma immunohistochemistry
  • 相关文献

同被引文献22

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1379
  • 2何利丽,冯一中,顾永平.胰腺癌中内皮抑素表达与微血管密度测定的意义[J].临床与实验病理学杂志,2005,21(3):335-338. 被引量:4
  • 3Weidner N. Intratumor microvessel density as a prognostic factor in cancer [ J ]. Am J Pathol, 1995,147 ( 1 ) :9 - 19.
  • 4Guenther U, Herbst H, Bauer M, et al. Collagen type X Ⅷ/endostatin is differentially expressed in primary and metastatic colorectal cancers and ovarian carcinomas [ J ]. Br J Cancer, 2001,85(10) :1540 -5.
  • 5Feldman AL,Pak H, Yang JC, et al. Serum endostatin levels are elevated in patients with soft tissue sarcoma[ J]. Cancer,2001,91(8) :1525 -9.
  • 6Morimoto T,Aoyagi M,Tamaki M,et al. Increased levels of tissue endostatin in human malignant gliomas [ J ]. Clin Cancer Res,2002,8 ( 9 ) :2933 - 8.
  • 7Hata K, Fujiwaki R, Nakayama K,et al. Expression of the endostatin gene in epithelial ovarian cancer[ J]. Clin Cancer Res,2001,7(8) :2405 -9.
  • 8Feldman AL,Tamarkin L, Paciotti GF,et al. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage Ⅳ clear cell renal cancer [J]. Clin Cancer Res,2000,6(12) :4628 -34.
  • 9Shaarawy M, El-Sharkawy SA. Biomarkers of intrinsic angiogenic and anti-angiogenic activity in patients with endometrial hyperplasia and endometrial cancer[J]. Acta Oncologic,2001,40(4) :513-8.
  • 10Dhanabal M, Ramchandran R, Waterman MJ, et al. endostatin induces endothelial cell apoptosis [ J ]. J Biol Chem, 1999, 274(17) :11721 -6.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部